TENS Treatment for Bedwetting
Launched by ALBANY MEDICAL COLLEGE · Mar 16, 2020
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a TENS (Transcutaneous Electrical Nerve Stimulation) unit for treating bedwetting in children, which is also known as nocturnal enuresis. Children who wet the bed more than once a week and have not had success with behavioral changes, like limiting drinks before bed, may be eligible to participate. To join, they must also be able to understand the study and meet certain health criteria, such as not having any serious medical conditions or previous treatments for bedwetting.
In the trial, children who choose to use the TENS unit will be divided into three groups, each using a different frequency setting on the device. They will use the TENS unit on their ankle for 15 minutes each night for 30 days and keep a diary to track their bedwetting episodes. After the treatment period, researchers will follow up to see how the TENS therapy has affected the children’s quality of life and bedwetting frequency. This study is important as it explores a new option for families dealing with bedwetting, helping to identify potential benefits and improve treatment strategies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Presenting with nocturnal enuresis (more than 1x a week)
- • 2. Failed Behavioral modification treatment (limiting evening drinking, double voiding prior to bedtime, bowel habits, social anxiety factors)
- • 3. Ability to provide informed consent and assent and complete study requirements
- Exclusion Criteria:
- • 1. Patients who have previously tried pharmacologic treatment for nocturnal enuresis, neuromodulation or other alternative therapy for urologic disorders within the past 30 days
- • 2. Daytime incontinence symptoms
- • 3. Known "high volume" voiders (determined from history)
- • 4. Bedwetting episodes on the average of less than two times per week,
- • 5. Medications predisposing to incontinence (eg, Lithium for bipolar disorder)
- • 6. Other known voiding or neurologic disorders (eg, overactive bladder, myelomeningocele, interstitial cystitis, etc)
- • 7. Secondary etiologies for nocturnal enuresis (eg, cystitis, obstructive sleep apnea, urinary fistulae, heart disease)
- • 8. Any contraindications to usage of a TENS unit (pacemaker or other implantable device, lymphedema, pregnancy, malignancy,bleeding or clotting disorders, unhealthy tissue, seizure disorders, impaired cognition)
- • 9. Any history of heart disease or complications
About Albany Medical College
Albany Medical College is a leading academic institution dedicated to advancing medical education, research, and healthcare delivery. As a prominent sponsor of clinical trials, the college focuses on innovative research initiatives that aim to improve patient outcomes and enhance understanding of various medical conditions. With a commitment to scientific excellence and ethical standards, Albany Medical College collaborates with experienced researchers and healthcare professionals to conduct rigorous clinical studies that contribute to the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albany, New York, United States
Patients applied
Trial Officials
Adam Howe, MD
Principal Investigator
Albany Medical College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials